Drug Trial Radar · NCT00002267
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
750
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- PharmaciaPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to assess the safety and the relative benefit of rifabutin monotherapy in preventing or delaying the incidence of Mycobacterium avium complex (MAC) bacteremia in AIDS patients with CD4 counts less than or equal to 200, as compared to placebo, and to assess if survival is prolonged in patients who receive rifabutin prophylaxis.
Conditions
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
Interventions
RifabutinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
43 sites in 2 countries. Site status is shown where the registry gives one.
Maricopa County Med Ctr
Phoenix, Arizona
East Bay AIDS Ctr
Berkeley, California
Pacific Oaks Med Group
Beverly Hills, California
AIDS Community Research Consortium
Redwood City, California
HIV Research Group
San Diego, California
Dr Larry A Waites
San Francisco, California
Saint Francis Mem Hosp / HIV Care
San Francisco, California
Dr Marcus Conant
San Francisco, California
San Francisco Veterans Administration Med Ctr
San Francisco, California
Dr Marshall Kubota
Santa Rosa, California
Dr Jeffrey Galpin
Tarzana, California
Miami Veterans Administration Med Ctr
Miami, Florida
Community Research Initiative of South Florida
Miami, Florida
Northwestern Univ Med School
Chicago, Illinois
AIDS Research Alliance - Chicago
Chicago, Illinois
Tulane Univ School of Medicine
New Orleans, Louisiana
Comprehensive AIDS Alliance of Detroit / Harper Hosp
Detroit, Michigan
Univ of Minnesota
Minneapolis, Minnesota
St Paul Ramsey Med Ctr
Saint Paul, Minnesota
Univ of Nevada / Veterans Administration Med Ctr
Reno, Nevada
North Jersey Community Research Initiative
Newark, New Jersey
Univ of New Mexico Hlth Sciences Ctr / Dept of Med
Albuquerque, New Mexico
Dr Donald Romig
Sante Fe, New Mexico
Albany Veterans Administration
Albany, New York
AIDS Services Erie County Med Ctr
Buffalo, New York
Community Health Network
Rochester, New York
Buckley Braffman Stern Med Associates
Philadelphia, Pennsylvania
Thomas Jefferson Med College
Philadelphia, Pennsylvania
Dr Alfred F Burnside Jr
Columbia, South Carolina
Infectious Disease Physicians Inc
Annandale, Virginia
Milwaukee County Med Complex
Milwaukee, Wisconsin
Univ of Calgary Health Science Ctr
Calgary, Alberta, Canada
Univ of Alberta/Division of Inf Dis/Dept of Med
Edmonton, Alberta, Canada
Saint Paul's Hosp
Vancouver, British Columbia, Canada
Victoria Gen Hosp
Halifax, Nova Scotia, Canada
McMaster Univ Med Ctr
Hamilton, Ontario, Canada
Ottawa Gen Hosp
Ottawa, Ontario, Canada
Mount Sinai Hosp
Toronto, Ontario, Canada
Saint Michael's Hosp
Toronto, Ontario, Canada
Sunnybrook Health Science Ctr
Toronto, Ontario, Canada
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.